Protocol Specific Research Support

协议特定研究支持

• 批准号: 7714248
• 负责人: FRANCO MUGGIA
• 金额: $ 1.01万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-18 至 2013-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7714248
• 关键词: Accounting; Cancer Center; Cancer Center Support Grant; Categories; Clinical; Clinical Trials; Commit; Data; Development; Disease Management; Funding; Grant; Investigation; Lead; Malignant Neoplasms; Peer Review; Phase; Phase I Clinical Trials; Pilot Projects; Protocols documentation; Purpose; Qualifying; Recommendation; Research Personnel; Research Support; Resources; Site Visit; Therapeutic; interest; novel; pilot trial; prevent; programs

CCSG funds for Protocol Specific Research Support (PSRS) are used for development of NYUCI investigator-initiated early phase protocols. The NYUCI places a high priority on such studies since they represent one of the most promising benefits of the NCI Cancer Centers Program. Accrual to investigatorinitiated studies at NYUCI has doubled over the last funding period and this category now accounts for two thirds of all accruals. Twenty three of the 38 studies in 2005 were phase I, phase l/ll, and pilot protocols thereby potentially qualifying for PSRS support. Strict criteria are used to allocate these funds including scientific priority assigned by the PRMC, recommendation by the appropriate Disease Management Group and/or CCSG scientific program, need for such resources, and likelihood that the study will lead to subsequent peer-reviewed funding or incorporation into cooperative group or consortium studies. The ultimate decision for allocating PSRS funds is made by the Clinical Cancer Investigation Committee.

CCSG为协议特定研究支持（PSRS）提供的资金用于NYUCI的发展